Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Vitronectin receptor antagonist pharmaceuticals

Vitronectin receptor antagonist pharmaceuticals

US Patent 6569402 · Granted May 27, 2003

Estimated economic value: $94,055,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treating chemotherapy induced neutropenia using fixed doses of eflape2024
Reagents for oxidizer-based chemical detection2022
Biocompatible N, N-disubstituted sulfonamide-containing fluorescent dye labels2019
Methods and compositions for identifying subjects at risk of developing stent th2018
Methods and apparatus for synthesizing imaging agents, and intermediates thereof2018
Fluorescent imaging agents2018
Biocompatible fluorescent metal oxide nanoparticles2018
N-alkoxyamide conjugates as imaging agents2017
Integrin targeting agents and in-vivo and in-vitro imaging methods using the sam2017
Compositions, methods, and systems for the synthesis and use of imaging agents2017
Reagents for oxidizer-based chemical detection2017
Biocompatible N, N-disubstituted sulfonamide-containing fluorescent dye labels2017